GNAS drives gastric cancer progression via pyrimidine metabolic reprogramming and immune-microenvironment remodeling

Apoptosis · Published 2026-07-28 · DOI 10.1007/s10495-026-02412-0

Authors (9)

Xinyi Wang, Heng Tian, Jiaju Wang, Yafen Wang, Ran Wei, Yuhan Liu, Yun Hong, Fan Wang, Bangjie Chen

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wang, X., Tian, H., Wang, J., et al. (2026). GNAS drives gastric cancer progression via pyrimidine metabolic reprogramming and immune-microenvironment remodeling. Apoptosis. https://doi.org/10.1007/s10495-026-02412-0

Related articles

• The autoimmune regulator (AIRE) is a target of the E3-Ubiquitin ligase Seven-in-absentia homolog 1 (SIAH1). · Apoptosis · 2026 · Same journal
• PSD3 links autophagic flux to MHC-I–associated immune modulation in esophageal squamous cell carcinoma · Apoptosis · 2026 · Same journal
• Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4 · Apoptosis · 2026 · Same journal
• H4K8 lactylation-mediated ferroptosis defense drives EGFR-TKI resistance in lung adenocarcinoma · Apoptosis · 2026 · Same journal
• A novel ZNF263-SMOX-ROS-TRIB3 signaling axis drives Wnt/β-catenin activation and metastatic progression in colorectal cancer · Apoptosis · 2026 · Same journal
• Microglial tunneling nanotubes: an intercellular transfer facilitating mitochondrial dysfunction and neuroinflammation in experimental cerebral malaria · Apoptosis · 2026 · Same journal
• Retiring M1/M2: a view from the succinate receptor · Apoptosis · 2026 · Same journal
• Identifying Neddylation-modified features to assess prognosis and immune efficacy in hepatocellular carcinoma · Apoptosis · 2026 · Same journal
• Apoptotic bodies in bone homeostasis and skeletal disease: biology and therapeutic implications · Apoptosis · 2026 · Same journal
• A pH-responsive silver nanoparticle platform overcomes MEK inhibitor resistance in neurofibroma via triacsin C-mediated lipid metabolic reprogramming · Apoptosis · 2026 · Same journal